<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-15">
<META content="MSHTML 6.00.6000.16640" name=GENERATOR></HEAD>
<BODY style="MARGIN: 4px 4px 1px; FONT: 10pt Tahoma">
<DIV><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:SmartTagType name="PostalCode" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="State" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="City" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="Street" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="address" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="PlaceType" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="PlaceName" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType name="place" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:SmartTagType>
<STYLE>
st1\:*{behavior:url(#default#ieooui) }
</STYLE>
<STYLE>
<!--
/* Font Definitions */
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman";
mso-believe-normal-left:yes;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
{mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:10.0pt;
font-family:"Times New Roman";
font-weight:bold;}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{color:blue;
text-decoration:underline;}
p.Figure, li.Figure, div.Figure
{mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
text-align:justify;
font-size:10.0pt;
font-family:Arial;
font-weight:bold;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:Arial;
color:navy;}
@page Section1
{size:612.0pt 792.0pt;
margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.Section1
{page:Section1;}
-->
</STYLE>
If you could use different wavelengths during the same run to quantify different components you would need to collect data at peaks or minima to avoid bouncing in the abs values between scans.</DIV>
<DIV> </DIV>
<DIV>Sedanal allows you to build any model you can conceive of for fitting velocity or equil data. So a 2A <-> A2 plus an A + I <-> AI model with or without slow kinetics is easily constructed for velocity data. Independent knowledge of K's would help for uncolored components, but in principle you can analyze it this way. Best to contact Walter Stafford for getting it up and running in your facility. Good luck.</DIV>
<DIV> </DIV>
<DIV>& I just saw John Philo's comments & agree its critical to use areas under the curves. Sedanal also does g(s) and normalization but using an integrate function in Sedfit and normalizing later should also work. Comparing zones in this way, especially from different wavelength data, can reveal interesting heterogeneity in complex systems as well.</DIV>
<DIV> </DIV>
<DIV><BR><BR>>>> On 5/20/2008 at 10:54 AM, in message <20080520165443078.00000001524@ThomasJowitt>, "Thomas Jowitt" <thomas.a.jowitt@manchester.ac.uk> wrote:<BR></DIV>
<DIV style="PADDING-LEFT: 7px; MARGIN: 0px 0px 0px 15px; BORDER-LEFT: #050505 1px solid; BACKGROUND-COLOR: #f3f3f3">
<DIV class=Section1>
<P class=MsoNormal><FONT face=Arial color=navy size=2><SPAN style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">Thanks John<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal><FONT face=Arial color=navy size=2><SPAN style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">This is a slowly interacting system that we have characterized using the kds from sed eq. however it is complicated by the fact that it is partially calcium dependant, although they do interact slowly when no calcium is present (at least non-added). I will have a look at the DCDT plots and try to normalize them there. We are attempting to compete with fragments of the same molecule to establish which domains are responsible for dimerisation, therefore no color unfortunately. You are right in that the concentration of competition fragments is critical and we can see competition with some of the fragments. Only quantifying between different runs at different wavelengths is tricky. <o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal><FONT face=Arial color=navy size=2><SPAN style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">I am not familiar with competitor models for direct boundary fitting.<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal><FONT face=Arial color=navy size=2><SPAN style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial">Tom<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal><FONT face=Arial color=navy size=2><SPAN style="FONT-SIZE: 10pt; COLOR: navy; FONT-FAMILY: Arial"><o:p> </o:p></SPAN></FONT></P>
<DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center" align=center><FONT face="Times New Roman" size=3><SPAN style="FONT-SIZE: 12pt">
<HR tabIndex=-1 align=center width="100%" SIZE=2>
</SPAN></FONT></DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><B><FONT face=Tahoma size=2><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Tahoma">From:</SPAN></FONT></B><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"> John Correia [mailto:jcorreia@biochem.umsmed.edu] <BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> 20 May 2008 15:34<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> thomas.a.jowitt@manchester.ac.uk; rasmb@rasmb.bbri.org<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> Re: [RASMB] Sedfit peak integration</SPAN></FONT><o:p></o:p></P></DIV>
<P class=MsoNormal><FONT face="Times New Roman" size=3><SPAN style="FONT-SIZE: 12pt"><o:p> </o:p></SPAN></FONT></P>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma">Tom<o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"> <o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma">You described a noninteracting or slowly interacting system. A reversible monomer dimer system is one peak, skewed near the mid point of the transition. For a reversible system plot Sw vs total concentrations to observe the extent of dimerization. This requires a Kd in the accessible concentration regime. If you see two peaks its nonreversible or slow kinetics, possibly disulfide crosslinking. Tight competitive binding with an inhibitor might produce a free monomer zone but the expected shape or resolution into two zones will depend upon the relative affinity of competitor with Kd for dimerization. A simple assumption in your analysis may be too simple. Direct boundary fitting to a competitive model is also possible. Does the inhibitor have color? Knowing inhibitor concentration is a critical feature for this analysis. Normalization of the peaks often makes it easier to see the transition or changes in boundary shape but this is a qualitative analysis. Use the total area under the curves to normalize. Some programs like DCDT+ have a normalization function built in.<o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"> <o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"> <o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"> <o:p></o:p></SPAN></FONT></P></DIV>
<DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma">-------------------------------------------------------------------<BR>Dr. John J. "Jack" Correia<BR>Department of Biochemistry<BR>University of <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /><st1:place w:st="on"><st1:PlaceName w:st="on">Mississippi</st1:PlaceName> <st1:PlaceName w:st="on">Medical</st1:PlaceName> <st1:PlaceType w:st="on">Center</st1:PlaceType></st1:place><BR><st1:Street w:st="on"><st1:address w:st="on">2500 North State Street</st1:address></st1:Street><BR><st1:place w:st="on"><st1:City w:st="on">Jackson</st1:City>, <st1:State w:st="on">MS</st1:State> <st1:PostalCode w:st="on">39216</st1:PostalCode></st1:place><BR>(601) 984-1522 <BR>fax (601) 984-1501 <BR>email address: jcorreia@biochem.umsmed.edu <BR>homepage location: <A href="http://biochemistry.umc.edu/correia.html">http://biochemistry.umc.edu/correia.html</A><BR>dept homepage location: <A href="http://biochemistry.umc.edu/">http://biochemistry.umc.edu/</A><BR>-------------------------------------------------------------------<BR><BR><BR><BR><BR>>>> On 5/20/2008 at 9:05 AM, in message <20080520150555687.00000003664@ThomasJowitt>, "Thomas Jowitt" <thomas.a.jowitt@manchester.ac.uk> wrote:<o:p></o:p></SPAN></FONT></P></DIV>
<DIV style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0cm; BORDER-TOP: medium none; PADDING-LEFT: 5pt; PADDING-BOTTOM: 0cm; MARGIN-LEFT: 11.25pt; BORDER-LEFT: #050505 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: medium none">
<DIV>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Hello<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><o:p> </o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">I have a question regarding peak integration between different sedfit analyses. In an effort to gauge competition in a self-associating system, velocity was used to assess the level of dimerisation and subsequent competition using different concentrations of dimer and the competing element. The question is one of assessing the relative degree of competition, therefore the integration or relative size of the peaks. Is it right to normalize the different runs to the height of the dimer (predominant species), and therefore compare the relative size of the monomer peaks for competition, and if so can the integrated value of the normalized peaks be used also, or is that more subjective?<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><o:p> </o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Thanks for any thoughts<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><o:p> </o:p></SPAN></FONT></P>
<P class=MsoNormal style="BACKGROUND: #f3f3f3"><FONT face=Arial size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Tom Jowitt<o:p></o:p></SPAN></FONT></P></DIV></DIV>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT face=Tahoma size=2><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma"><BR clear=all>Individuals who have received this information in error or are not authorized to receive it must promptly return or dispose of the information and notify the sender. Those individuals are hereby notified that they are strictly prohibited from reviewing, forwarding, printing, copying, distributing or using this information in any way. <o:p></o:p></SPAN></FONT></P></DIV></DIV><br clear=all> Individuals who have received this information in error or are not authorized to receive it must promptly return or dispose of the information and notify the sender. Those individuals are hereby notified that they are strictly prohibited from reviewing, forwarding, printing, copying, distributing or using this information in any way.
</BODY></HTML>